Acute Effects of Myofascial Release in Individuals With Text Neck Syndrome
Launched by KARABUK UNIVERSITY · May 20, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a technique called myofascial release therapy can help people with Text Neck Syndrome (TNS), which is neck pain caused by looking down at smartphones and other devices for long periods. The study will involve a single session of myofascial release to see if it can reduce neck pain, improve how well participants can move their neck, and enhance their overall neck function. Participants will be asked to rate their neck pain before and after the treatment, and the study is focused on people aged 18 to 40 who use a mobile device for at least three hours a day and experience symptoms like neck pain or headaches.
To be eligible for the study, participants must meet specific criteria, such as being within the age range and experiencing certain symptoms related to TNS. However, individuals with certain medical conditions, like severe neck injuries or neurological disorders, cannot participate. If you join the study, you can expect to receive the therapy and be assessed for changes in pain and movement right before and after the session. This research could help improve understanding and treatment options for those suffering from neck pain linked to modern technology use.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged between 18 and 40 years (inclusive)
- • Uses a mobile device for ≥3 hours/day
- * Reports at least 3 out of the following 6 symptoms associated with Text Neck Syndrome (TNS):
- • Neck pain Shoulder pain Back pain Headache Insomnia Numbness/tingling in hands
- • -Voluntarily agrees to participate and provides informed consent
- Exclusion Criteria:
- • History of congenital, traumatic, or surgical pathology affecting the cervical -------spine or shoulder region
- • Neurological disorders that cause headaches (e.g., migraines due to underlying neurological conditions)
- • Presence of inflammatory, infectious spinal diseases, or diagnosed spinal deformities
- • Received trigger point injections in the cervical region within the past 6 months
About Karabuk University
Karabuk University is a distinguished educational institution located in Turkey, dedicated to advancing scientific research and innovation across various fields, including healthcare. As a clinical trial sponsor, the university plays a pivotal role in facilitating cutting-edge research aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a commitment to ethical standards and rigorous scientific methodology, Karabuk University collaborates with healthcare professionals and researchers to design and implement clinical trials that address pressing health challenges, ultimately striving to enhance treatment options and promote public health initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karabük, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported